FIELD: medicine, pharmaceutical compositions.
SUBSTANCE: invention relates to composition containing estrogen and other estrogen-like hormones except for androgens, in combination with ascorbic acid, lysine, proline and other substances for prevention and treatment of pathological conditions associated with cell matrix degeneration caused by therapy using estrogen or estrogen-like hormones as side effects.
EFFECT: reduced side effect in process of prolonged hormonal treatment with estrogens.
9 cl
Authors
Dates
2006-08-27—Published
2001-12-14—Filed